People with acne have been raving about a miracle 6p tablet that could leave your skin silky smooth once more - and it apparently also does wonders with your hair and nails ...

The Chinese Phase III study (NCT06192264), which was conducted by Ascletis, saw denifanstat achieve a 33.2% treatment success in patients with acne vulgaris taking the oral medication for 12 weeks.

Unlike other PMS symptoms, period-related acne doesn’t always go away once your period starts. Here’s how to soothe any active breakouts, prevent future flare-ups, and more.

--Ascletis Pharma Inc. today announces completion of enrollment of 480 patients for Phase III clinical trial of ASC40 o nce-daily oral tablet for treatment of moderate to severe acne. On May 2 ...

Get clear skin after acne: Here's how to remove pimple scars Acne scars can often outlast the pimples themselves, turning it into a long-term skin concern.

Sagimet Bioscience’s denifanstat, a one-daily pill for the treatment of acne, has succeeded in a Phase III trial, with the biotech’s license partner Ascletis Bioscience set to submit the drug ...

HANGZHOU, China, Nov. 12, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces completion of enrollment of 480 patients for Phase III clinical trial of ASC40 (denifanstat ...

-Phase III trial enrolled a total of 480 patients with moderate to severe acne-Topline results expected in the second quarter 2025 HANGZHOU, China, Nov. 12, 2024 /PRNewswire/ -- Ascletis Pharma ...